Skip to main content
Clinical Trials/CTRI/2022/05/042749
CTRI/2022/05/042749
Recruiting
Phase 3

A Clinico-Etiopathological Study To Compare The Efficacy Of Ashwagandha Churna And Amalaki Churna in Post COVID Fatigue Patients-A Randomized Open Label Parallel Group Trial

Ch Brahm Prakash Ayurved Charak Sansthan0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Sponsor
Ch Brahm Prakash Ayurved Charak Sansthan
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Ch Brahm Prakash Ayurved Charak Sansthan

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients Recovered From COVID\-19\.

Exclusion Criteria

  • 1\. Pregnant Women And Lactating Mothers.
  • 2\. Patients with Severe Dyspnoea.
  • 3\. Patients Having Co Morbidities.

Outcomes

Primary Outcomes

Not specified

Similar Trials